Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis.

Weber H, Klamer D, Freudenberg F, Kittel-Schneider S, Rivero O, Scholz CJ, Volkert J, Kopf J, Heupel J, Herterich S, Adolfsson R, Alttoa A, Post A, Grußendorf H, Kramer A, Gessner A, Schmidt B, Hempel S, Jacob CP, Sanjuán J, Moltó MD, Lesch KP, Freitag CM, Kent L, Reif A.

Eur Neuropsychopharmacol. 2014 Jan;24(1):65-85. doi: 10.1016/j.euroneuro.2013.09.005.

PMID:
24220657
2.

Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.

Freudenberg F, Alttoa A, Reif A.

Genes Brain Behav. 2015 Jan;14(1):46-63. doi: 10.1111/gbb.12193. Review.

3.

A putative cis-acting polymorphism in the NOS1 gene is associated with schizophrenia and NOS1 immunoreactivity in the postmortem brain.

Cui H, Nishiguchi N, Yanagi M, Fukutake M, Mouri K, Kitamura N, Hashimoto T, Shirakawa O, Hishimoto A.

Schizophr Res. 2010 Aug;121(1-3):172-8. doi: 10.1016/j.schres.2010.05.003.

PMID:
20605417
4.

No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.

Okumura T, Okochi T, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Tsunoka T, Ujike H, Inada T, Ozaki N, Iwata N.

Neuromolecular Med. 2009;11(2):123-7. doi: 10.1007/s12017-009-8068-z.

PMID:
19513863
5.

A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function.

Reif A, Herterich S, Strobel A, Ehlis AC, Saur D, Jacob CP, Wienker T, Töpner T, Fritzen S, Walter U, Schmitt A, Fallgatter AJ, Lesch KP.

Mol Psychiatry. 2006 Mar;11(3):286-300.

PMID:
16389274
6.

A functional promoter polymorphism of neuronal nitric oxide synthase moderates prefrontal functioning in schizophrenia.

Reif A, Schecklmann M, Eirich E, Jacob CP, Jarczok TA, Kittel-Schneider S, Lesch KP, Fallgatter AJ, Ehlis AC.

Int J Neuropsychopharmacol. 2011 Aug;14(7):887-97. doi: 10.1017/S1461145710001677.

PMID:
21281558
7.

Identification of a schizophrenia-associated functional noncoding variant in NOS1AP.

Wratten NS, Memoli H, Huang Y, Dulencin AM, Matteson PG, Cornacchia MA, Azaro MA, Messenger J, Hayter JE, Bassett AS, Buyske S, Millonig JH, Vieland VJ, Brzustowicz LM.

Am J Psychiatry. 2009 Apr;166(4):434-41. doi: 10.1176/appi.ajp.2008.08081266. Erratum in: Am J Psychiatry. 2010 Jul;167(7):870.

8.

Unexpected Heterodivalent Recruitment of NOS1AP to nNOS Reveals Multiple Sites for Pharmacological Intervention in Neuronal Disease Models.

Li LL, Melero-Fernandez de Mera RM, Chen J, Ba W, Kasri NN, Zhang M, Courtney MJ.

J Neurosci. 2015 May 13;35(19):7349-64. doi: 10.1523/JNEUROSCI.0037-15.2015.

9.

Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls.

Zhang Z, Chen X, Yu P, Zhang Q, Sun X, Gu H, Zhang H, Zhai J, Chen M, Du B, Deng X, Ji F, Wang C, Xiang Y, Li D, Wu H, Li J, Dong Q, Chen C.

Neuropsychopharmacology. 2015 May;40(6):1383-94. doi: 10.1038/npp.2014.323.

10.

Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder.

Silberberg G, Ben-Shachar D, Navon R.

Am J Med Genet B Neuropsychiatr Genet. 2010 Oct 5;153B(7):1318-28. doi: 10.1002/ajmg.b.31112.

PMID:
20645313
11.

Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controls.

Nicodemus KK, Law AJ, Radulescu E, Luna A, Kolachana B, Vakkalanka R, Rujescu D, Giegling I, Straub RE, McGee K, Gold B, Dean M, Muglia P, Callicott JH, Tan HY, Weinberger DR.

Arch Gen Psychiatry. 2010 Oct;67(10):991-1001. doi: 10.1001/archgenpsychiatry.2010.117.

12.

[Association study of NOS1 gene polymorphisms and schizophrenia].

Wang J, Ma XH, Xiang B, Wu JY, Wang YC, Deng W, Li ML, Wang Q, He ZL, Li T.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2012 Aug;29(4):459-63. doi: 10.3760/cma.j.issn.1003-9406.2012.04.018. Chinese.

PMID:
22875507
13.

Polymorphisms in the nitric oxide synthase 1 gene are associated with severe chronic rhinosinusitis.

Zhang Y, Endam LM, Filali-Mouhim A, Bossé Y, Castano R, Desrosiers M.

Am J Rhinol Allergy. 2011 Mar-Apr;25(2):e49-54. doi: 10.2500/ajra.2011.25.3588.

PMID:
21679499
14.

NOS1 ex1f-VNTR polymorphism influences prefrontal brain oxygenation during a working memory task.

Kopf J, Schecklmann M, Hahn T, Dresler T, Dieler AC, Herrmann MJ, Fallgatter AJ, Reif A.

Neuroimage. 2011 Aug 15;57(4):1617-23. doi: 10.1016/j.neuroimage.2011.05.034.

PMID:
21620982
15.

Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia.

Shinkai T, Ohmori O, Hori H, Nakamura J.

Mol Psychiatry. 2002;7(6):560-3.

16.

Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans.

Reif A, Jacob CP, Rujescu D, Herterich S, Lang S, Gutknecht L, Baehne CG, Strobel A, Freitag CM, Giegling I, Romanos M, Hartmann A, Rösler M, Renner TJ, Fallgatter AJ, Retz W, Ehlis AC, Lesch KP.

Arch Gen Psychiatry. 2009 Jan;66(1):41-50. doi: 10.1001/archgenpsychiatry.2008.510.

PMID:
19124687
17.

A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization.

Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O'Donnell CJ, Hirschhorn JN, Kääb S, Spooner PM, Meitinger T, Chakravarti A.

Nat Genet. 2006 Jun;38(6):644-51.

PMID:
16648850
18.

Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.

AlFadhli S, Mohammed EM, Al Shubaili A.

Ann Hum Biol. 2013 Jul;40(4):368-75. doi: 10.3109/03014460.2013.786756.

PMID:
23826716
19.

The NOS1 variant rs6490121 is associated with variation in prefrontal function and grey matter density in healthy individuals.

Rose EJ, Greene C, Kelly S, Morris DW, Robertson IH, Fahey C, Jacobson S, O'Doherty J, Newell FN, McGrath J, Bokde A, Garavan H, Frodl T, Gill M, Corvin AP, Donohoe G.

Neuroimage. 2012 Mar;60(1):614-22. doi: 10.1016/j.neuroimage.2011.12.054.

PMID:
22227051
20.

The effect of a promoter polymorphism on the transcription of nitric oxide synthase 1 and its relevance to Parkinson's disease.

Rife T, Rasoul B, Pullen N, Mitchell D, Grathwol K, Kurth J.

J Neurosci Res. 2009 Aug 1;87(10):2319-25. doi: 10.1002/jnr.22045.

PMID:
19326438
Items per page

Supplemental Content

Support Center